Mark Austin
Director of Finance/CFO en PERSPECTIVE THERAPEUTICS, INC. .
Fortuna: 99 996 $ al 31/03/2024
Perfil
Mark J.
Austin is currently working as the Co-CFO, Secretary, CAO, VP & Controller at Perspective Therapeutics, Inc. He previously worked as the Chief Financial & Accounting Officer at IsoRay, Inc. from 2017 to 2018.
Prior to that, he held the position of Manager & Senior Associate at KPMG Advisory Sp zoo Spolka Komandytowa from 2009 to 2017.
Mr. Austin completed his undergraduate degree at Santa Clara University.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
23/04/2024 | 84 030 ( 0.01% ) | 99 996 $ | 31/03/2024 |
Cargos activos de Mark Austin
Empresas | Cargo | Inicio |
---|---|---|
PERSPECTIVE THERAPEUTICS, INC. | Director of Finance/CFO | 01/07/2017 |
Antiguos cargos conocidos de Mark Austin.
Empresas | Cargo | Fin |
---|---|---|
KPMG Advisory SP ZOO Spolka Komandytowa
KPMG Advisory SP ZOO Spolka Komandytowa Investment ManagersFinance Part of KPMG CEE Holdings Ltd., KPMG Advisory Sp zoo Spolka Komandytowa provides financial advisory services. The private company is based in Warsaw, Poland. | Corporate Officer/Principal | 01/07/2017 |
IsoRay, Inc.
IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | Director of Finance/CFO | - |
Formación de Mark Austin.
Santa Clara University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 3 |
---|---|
IsoRay, Inc.
IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | Health Technology |
KPMG Advisory SP ZOO Spolka Komandytowa
KPMG Advisory SP ZOO Spolka Komandytowa Investment ManagersFinance Part of KPMG CEE Holdings Ltd., KPMG Advisory Sp zoo Spolka Komandytowa provides financial advisory services. The private company is based in Warsaw, Poland. | Finance |
Perspective Therapeutics, Inc. |
- Bolsa de valores
- Insiders
- Mark Austin